The effect of differing rates and injection sites on the amount of protamine delivered before detection of hemodynamic alterations in dogs

Veterinary Surgery

Volumn 29, Issue 5, 2000, Pages 442-448

  Morgan, M R ^a   Monnet, E ^a,b   Gaynor, J S ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

CARDIOTONIC AGENT; DOBUTAMINE; HEPARIN ANTAGONIST;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; ARTICLE; BLEEDING; BLOOD; CORONARY ARTERY BYPASS GRAFT; DOG; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HEMODYNAMICS; MALE; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD LOSS, SURGICAL; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DOBUTAMINE; DOGS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMODYNAMIC PROCESSES; HEPARIN ANTAGONISTS; MALE; PROSPECTIVE STUDIES; RANDOM ALLOCATION;

EID: 0034264989     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1053/jvet.2000.9136     Document Type: Article

References (43)

1. Gravlee GP: Anticoagulation for cardiopulmonary bypass, in Gravlee GP, Davis RF, Utley JR (eds): Cardiopulmonary bypass: Principles and Practice. Baltimore, MD, Williams & Wilkins, 1993, pp 340-380
2. Monnet E, Orton EC, Gaynor JS, et al: Open resection of subvalvular aortic stenosis. J Am Vet Med Assoc 209:1255-1261, 1996
3. Zilla P, Fasol R, Groskurth P, et al: Blood platelets and cardiopulmonary bypass operations: Recovery occurs after initial stimulation rather then continual activation. J Thorac Cardiovasc Surg 97:379-388,1989
4. Campbell FW, Edmunds H: Platelet function and cardiopulmonary bypass, in Gravlee GP, Davis RF, Utley JR (eds): Cardiopulmonary Bypass: Principles and Practice. Baltimore, MD, Williams & Wilkins, 1993, pp 407-435
5. Horrow JC: Protamine: A review of its toxicity. Anesth Analg 64:348-361, 1985
6. Gupta SK, Veith FJ, Ascer E, et al: Anaphylactoid reactions to protamine: An often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery. J Vasc Surg 9:342-350, 1989
7. Wakefield TW, Lindblad B, Stanley TJ, et al: Heparin and protamine use in peripheral vascular surgery: A comparison between surgeons of the Society for Vascular Surgery and the European Society for Vascular Surgery. Eur J Vasc Surg 8:193-198, 1994
8. Levy JH, Zaidan JR, Faraj B: Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. Anesth Analg 65:739-742, 1986
9. Morel DR, Zapol WM, Thomas SJ, et al: C5a and thromboxane generation associated with pulmonary vaso-and broncho-constriction during protamine reversal of heparin. Anesthesiology 66:597-604, 1987
10. Wakefield TW, Stanley JC: Intraoperative heparin anticoagulation and its reversal. Semin Vasc Surg 9:296-302, 1996
11. Patella V, Ciccarelli A, Lamparter-Schummert B, et al: Heterogeneous effects of protamine on human mast cells and basophils. Br J Anaesth 78:724-730, 1997
12. Oe M, Asou T, Morita S, Yasui H, et al: Protamine-induced hypotension in heart operations: Application of the concept of ventricular-arterial coupling. J Thorac Cardiovasc Surg 112:462-471, 1996
13. Akata T, Yoshitake J, Nakashima M, et al: Effects of protamine on vascular smooth muscle of rabbit mesenteric artery. Anesthesiology 75:833-846, 1991
14. Pearson PJ, Evora PR, Ayrancioglu K, et al: Protamine releases endothelium-derived relaxing factor from systemic arteries: A possible mechanism of hypotension during heparin neutralization. Circulation 86:289-294, 1992
15. Cavarocchi NC, Schaff HV, Orszulak TA, et al: Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery 98:525-530, 1985
16. Best N, Teisner B, Grudzinskas JG, et al: Classical pathway activation during an adverse response to protamine sulphate. Br J Anaesth 55:1149-1153, 1983
17. Hobbhahn J, Conzen PF, Habazettl H, et al: Heparin reversal by protamine in humans - Complement, prostaglandins, blood cells, and hemodynamics. J Appl Physiol 71:1415-1421, 1991
18. Conzen PF, Habazettl H, Gutmann R, et al: Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs. Anesth Analg 68:25-31, 1989
19. Horiguchi T, Enzan K, Mitsuhata H, et al: Heparin-protamine complexes cause pulmonary hypertension in goats. Anesthesiology 83:786-791, 1995
20. Hobbhahn J, Conzen P, Zenker B, et al: Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine. Anesth Analg 67:253-260, 1988
21. Montalescot G, Lowenstein E, Ogletree ML, et al: Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 82:1765-1777, 1990
22. Nuttall GA, Murray MJ, Bowie W: Protamine-heparin induced pulmonary hypertension in pigs: Effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Anesthesiology 74:138-145, 1991
23. Tan F, Jackman H, Skidgel RA, et al: Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins. Anesthesiology 70:267-275, 1989
24. Sharath MD, Metzger WJ, Richerson HB, et al: Protamine-induced fatal anaphylaxis: Prevalence of antiprotamine immunolglobulin E antibody. J Thorac Cardiovasc Surg 9:86-90, 1985
25. Weiss ME, Nyhan D, Peng Z, et al: Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 320:886-892, 1989
26. Moorman RM, Zapol WM, Lowenstein E: Neutralization of heparin anticoagulation, in Gravlee GP, Davis RF, Utley JR (eds): Cardiopulmonary Bypass: Principles and Practice. Baltimore, MD, Williams & Wilkins, 1993, pp 381-406
27. Salmenper MT, Levy JH, Harker LA: Hemostasis and cardiopulmonary bypass, in Mora CT, Guyton RA, Finlayson DC, Rigatti RL (eds): Cardiopulmonary Bypass: Principles and Techniques of Extracorporeal Circulation. New York, NY, Springer-Verlag, 1995, pp 88-113
28. Casthely PA, Goodman K, Fyman PN, et al: Hemodynamic changes after the administration of protamine. Anesth Analg 65:78-80, 1986
29. Kronenfeld MA, Garguila R, Weinberg P, et al: Left atrial injection of protamine does not reliably prevent pulmonary hypertension. Anesthesiology 67:578-580, 1987
30. Goldman BS, Joison J, Austen WG: Cardiovascular effects of protamine sulfate. Ann Thorac Surg 7:459-471, 1969
31. Taylor RL, Little WC, Freeman GL, et al: Comparison of the cardiovascular effects of intravenous and intraaortic protamine in the conscious and anesthetized dog. Ann Thorac Surg 42:22-26, 1986
32. Cherry DA, Chiu RCJ, Wynands JE, et al: Intra-aortic vs intravenous administration of protamine: A prospective randomized clinical study. Surg Forum 36:238-240, 1985
33. Pauca AL, Graham JE, Hudspeth AS: Hemodynamic effects of intraaortic administration of protamine. Ann Thorac Surg 35:637-642, 1983
34. Morel DR, Costabella PMM, Pittet JF: Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent. Anesthesiology 73:415-424, 1990
35. Wakefield TW, Hantier CB, Wrobleski SK, et al: Effects of differing rates of protamine reversal of heparin anticoagulation. Surgery 119:123-128, 1996
36. Jacques, LB. A study of the toxicity of the protamine, salmine. Br J Pharmacol 4:135-144, 1949
37. Dorman BH, Elliott BM, Spinale FG, et al: Protamine use during peripheral vascular surgery: A prospective randomized trial. J Vasc Surg 22:248-256, 1995
38. Robinson RJ, Peigh PS, Fiore AC, et al: Venous prostheses: Improved patency with external stents. J Surg Research 36:306-311, 1984
39. Patel M, Arnell RE, Sauvage LR, et al: Experimental evaluation of ten clinically used arterial prostheses. Ann Vasc Surg 6:244-251, 1992
40. Stoelting RK, Henry DP, Verburg KM, et al: Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs. Can Anaesth Soc J 31:534-540, 1984
41. Morel DR, Lowenstein E, Nguyenduy T, et al: Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Circ Research 62:905-915, 1988
42. Fiser WP, Fewell JE, Hill DE, et al: Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin. J Thorac Cardiovasc Surg 89:63-70, 1985
43. Rich S, Braunwald E, Grossman W: Pulmonary hypertension, in Braunwald E (ed): Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia, PA, Saunders, 1997, pp 780-806